Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China

Detalles Bibliográficos
Autores principales: Liu, Huiqin, Wang, Ying, He, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847066/
https://www.ncbi.nlm.nih.gov/pubmed/36652112
http://dx.doi.org/10.1186/s13561-023-00419-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847066/
https://www.ncbi.nlm.nih.gov/pubmed/36652112
http://dx.doi.org/10.1186/s13561-023-00419-w

Ejemplares similares